Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spatially Fractionated Radiotherapy for Bulky or Refractory Solid Tumors: Efficacy and Toxicity

NCT07774819 is registered in ClinicalTrials.gov with Xu Zhi-yuan as lead sponsor.

NCT NCT07774819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07774819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spatially Fractionated Radiotherapy for Bulky or Refractory Solid Tumors: Efficacy and Toxicity
Lead sponsor
Xu Zhi-yuan
Phase
Phase 1/2
Overall status
Recruiting
Start date
December 19, 2024
Completion date
December 31, 2028
Enrollment
126 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiotherapy-induced immune priming